Kuehne+Nagel UAE, the regional arm of the global transport and logistics company, has received certification from the Emirates Drug Establishment (EDE).
The EDE certification authorizes Kuehne+Nagel for the storage and possession of raw pharmaceutical materials at its facility in Dubai South. This complements the company’s existing license to store medical products.
Emirates Drug Establishment (EDE) is the UAE’s independent regulatory authority overseeing the pharmaceutical and medical device sectors. As part of the licensing process, Kuehne+Nagel’s appointed pharmacist, Safa Alkhayat, underwent a formal assessment and was subsequently licensed to handle raw materials in accordance with Good Manufacturing Practice (GMP) standards.
This individual certification formed the basis for Kuehne+Nagel’s authorization by the Ministry of Health to store pharmaceutical starting materials, including excipients and active pharmaceutical ingredients (APIs).
Leon Diradourian MD – GCC Cluster Kuehne+Nagel
“This EDE certification marks a significant milestone in strengthening Kuehne+Nagel’s healthcare and life sciences supply chain offering. It benefits customers across all stages of the production cycle in the healthcare industry.”
Kuehne+Nagel in the UAE operates a 42,000 sqm fulfilment facility, including 25,500 sqm of temperature-controlled space dedicated to healthcare products.
The site features cold chambers (2–8°C) and restricted-access chambers compliant with GxP standards, encompassing Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and Good Storage Practice (GSP), supported by rigorous security protocols.
The fulfilment and distribution centre in EZDubai, a dedicated eCommerce zone in Dubai South, is closely located to Al Maktoum International Airport and connected to Jebel Ali Port via a bonded logistics corridor.
